Early Post-Marketing Study of ELIQUIS (Apixaban) in Mexico
NCT02345343
·
clinicaltrials.gov ↗
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Deep Vein Thrombosis
Pulmonary Embolism
Interventions
DRUG:
Apixaban
Sponsor
Bristol-Myers Squibb